rs185628131

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000293.3(PHKB):​c.1127-14A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000485 in 1,391,076 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 2 hom. )

Consequence

PHKB
NM_000293.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.02

Publications

0 publications found
Variant links:
Genes affected
PHKB (HGNC:8927): (phosphorylase kinase regulatory subunit beta) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, encoded by this gene, which is a member of the phosphorylase b kinase regulatory subunit family. The gamma subunit also includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9B, also known as phosphorylase kinase deficiency of liver and muscle. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. Two pseudogenes have been found on chromosomes 14 and 20, respectively.[provided by RefSeq, Feb 2010]
PHKB Gene-Disease associations (from GenCC):
  • glycogen storage disease IXb
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-47594123-A-G is Benign according to our data. Variant chr16-47594123-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00244 (372/152184) while in subpopulation AFR AF = 0.00821 (341/41540). AF 95% confidence interval is 0.00749. There are 0 homozygotes in GnomAd4. There are 158 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000293.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHKB
NM_000293.3
MANE Select
c.1127-14A>G
intron
N/ANP_000284.1Q93100-1
PHKB
NM_001363837.1
c.1127-14A>G
intron
N/ANP_001350766.1Q93100-3
PHKB
NM_001031835.3
c.1106-14A>G
intron
N/ANP_001027005.1Q93100-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHKB
ENST00000323584.10
TSL:1 MANE Select
c.1127-14A>G
intron
N/AENSP00000313504.5Q93100-1
PHKB
ENST00000566044.5
TSL:1
c.1106-14A>G
intron
N/AENSP00000456729.1Q93100-4
PHKB
ENST00000940565.1
c.1205-14A>G
intron
N/AENSP00000610624.1

Frequencies

GnomAD3 genomes
AF:
0.00245
AC:
373
AN:
152066
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00823
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000565
AC:
140
AN:
247988
AF XY:
0.000379
show subpopulations
Gnomad AFR exome
AF:
0.00812
Gnomad AMR exome
AF:
0.000263
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000892
Gnomad OTH exome
AF:
0.000498
GnomAD4 exome
AF:
0.000245
AC:
303
AN:
1238892
Hom.:
2
Cov.:
18
AF XY:
0.000196
AC XY:
123
AN XY:
628274
show subpopulations
African (AFR)
AF:
0.00864
AC:
252
AN:
29152
American (AMR)
AF:
0.000294
AC:
13
AN:
44170
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24718
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38488
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81088
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53152
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5284
European-Non Finnish (NFE)
AF:
0.0000209
AC:
19
AN:
909972
Other (OTH)
AF:
0.000359
AC:
19
AN:
52868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00244
AC:
372
AN:
152184
Hom.:
0
Cov.:
32
AF XY:
0.00212
AC XY:
158
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.00821
AC:
341
AN:
41540
American (AMR)
AF:
0.00144
AC:
22
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67990
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00216
Hom.:
1
Bravo
AF:
0.00255
Asia WGS
AF:
0.000581
AC:
2
AN:
3458

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Glycogen storage disease IXb (2)
-
-
2
not specified (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.5
DANN
Benign
0.76
PhyloP100
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs185628131; hg19: chr16-47628034; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.